What is TransAlgae?
Founded in 2004, TransAlgae operates at the intersection of biotechnology and industrial agriculture. The company specializes in the development and cultivation of enhanced algae strains designed to deliver high-value nutritional products for the aquaculture and animal husbandry sectors. By focusing on proprietary delivery mechanisms, TransAlgae addresses critical inefficiencies in traditional feed markets, positioning itself as a key innovator in the quest for sustainable, scalable protein and nutrient sources. Its market position is defined by a commitment to rigorous scientific research and the commercialization of algae-based additives that improve health outcomes and growth rates in livestock and aquatic species.
How much funding has TransAlgae raised?
TransAlgae has raised a total of $2.5M across 1 funding round:
Unspecified
$2.5M
Unspecified (2021): $2.5M with participation from Gan Shmuel Foods Ltd.
Key Investors in TransAlgae
Gan Shmuel Foods Ltd.
A prominent food industry entity with a focus on agricultural processing and supply chain integration, providing strategic support to innovative biotechnology firms.
What's next for TransAlgae?
With this major enterprise-level funding, TransAlgae is well-positioned to accelerate its commercial deployment and scale its production infrastructure. The strategic capital will likely be directed toward expanding manufacturing capacity and deepening research into new algae-derived compounds that meet the increasing regulatory and consumer demands for sustainable animal nutrition. As the company transitions into a more mature growth phase, the focus will shift toward securing broader market penetration and establishing long-term partnerships with global leaders in the aquaculture and husbandry industries. This trajectory suggests a robust outlook for the firm as it seeks to solidify its status as a foundational player in the global bio-economy.
See full TransAlgae company page
